On the quality of life of women with adenomyosis

Aim. To evaluate quality of life in women with adenomyosis using the Endometriosis Health Profile-5 questionnaire. Materials and methods . A total of 127 women with various forms of confirmed adenomyosis were studied. After the evaluation, all participants were divided into four groups according to the treatment method used. Results and discussion . Each woman was provided with a medical record that included the Endometriosis Health Profile (EHP-5+6) questionnaire, which was completed at the initial visit and again at 6 and 12 months after treatment. Analysis of the patients’ responses revealed differences in the impact of different treatment regimens on quality of life. Specifically, treatment with combined low-dose oral contraceptives (ethinyl estradiol + chlormadinone) and hysterectomy in cases of adenomyosis produced the best results, showing the greatest improvement in most quality-of-life domains. The Mirena LNG IUD was also effective, although to a lesser extent than the other two treatment groups. Conclusion. The use of standardized questionnaires to assess quality of life is an important tool for monitoring treatment efficacy and improving therapeutic approaches to adenomyosis. The choice of treatment strategy should be based on the woman’s age, reproductive plans and clinical symptoms. It is crucial to initiate treatment at the first clinical manifestation of the disease, with a therapy that is long-term, effective, and safe.